Holen Sie sich die Stockscreener-App
28.32
0.71%
0.20
Handel nachbörslich:
28.29
-0.03
-0.11%
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Olema Pharmaceuticals (NASDAQ:OLMA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD By Investing.com - Investing.com Canada
15,000 Shares in Olema Pharmaceuticals, Inc. $OLMA Bought by Titleist Asset Management LLC - MarketBeat
Olema Pharmaceuticals : Statement of Changes in Beneficial Ownership (Form 4) - MarketScreener
Dir Rappaport Acquires 35,868 Of Olema Pharmaceuticals Inc [OLMA] - TradingView
[Form 4] Olema Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Olema Pharmaceuticals Inc Stock Analysis and ForecastMarket Liquidity Analysis & Minimal Capital Appreciation - earlytimes.in
Olema Pharmaceuticals Reports Increased Losses Amid R&D Expansion - MSN
Olema Pharmaceuticals (OLMA): Evaluating the Current Valuation After a Strong Run-Up in Recent Months - Yahoo Finance
Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA) - MSN
LifeSci Capital Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA) - The Globe and Mail
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
The Goldman Sachs Group Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $26.00 - MarketBeat
Olema Oncology to Participate in Upcoming Investor Conferences - Sahm
Research Analysts Set Expectations for OLMA Q1 Earnings - MarketBeat
Small Cap Stocks To Keep An Eye OnNovember 18th - MarketBeat
Goldman Sachs Maintains Olema Pharmaceuticals (OLMA) Buy Recommendation - MSN
Olema Pharmaceuticals Inc. (OLMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - The Manila Times
Goldman Sachs Raises Price Target for Olema Pharmaceuticals (OLM - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 26%What's Next? - MarketBeat
Commit To Purchase Olema Pharmaceuticals At $16, Earn 40.4% Annualized Using Options - Nasdaq
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Olema Pharmaceuticals Closes $218.5 Million Public Offering of Common Stock - Quiver Quantitative
Olema Oncology (Nasdaq: OLMA) Completes $218.5M Equity Sale at $19 Per Share - Stock Titan
Olema Pharmaceuticals (NASDAQ:OLMA) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Olema Pharmaceuticals Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock - MarketScreener
What technical signals suggest for Olema Pharmaceuticals Inc. stockStop Loss & Momentum Based Trading Signals - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneProfit Target & AI Based Trade Execution Alerts - newser.com
Will Olema Pharmaceuticals Inc. continue its uptrendIPO Watch & Short-Term Swing Trade Alerts - newser.com
Potential Buying Opportunity for OLMA? - StocksToTrade
Is Olema Pharmaceuticals Inc. stock attractive for passive investorsWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Olema Pharmaceuticals Announces Public Stock Offering - TipRanks
Olema Pharmaceuticals Announces Follow-On Public Offering - TradingView
[8-K] Olema Pharmaceuticals, Inc. Reports Material Event | OLMA SEC FilingForm 8-K - Stock Titan
Forecasting Olema Pharmaceuticals Inc. price range with options data2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
What Fibonacci levels say about Olema Pharmaceuticals Inc. rebound2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Olema Pharmaceuticals Terminates ATM Prospectus - MSN
Olema Oncology prices $190.0 million public offering of common stock - MSN
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Expected to Rise, Oppenheimer Analyst Says - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
Olema Pharmaceuticals Has Nearly Tripled on Cancer Drug Hopes. How Should You Play OLMA Stock Here? - Barchart.com
Olema Pharmaceuticals: Shares Double On Roche's MBC DataI Preach Caution (NASDAQ:OLMA) - Seeking Alpha
JPMorgan Chase & Co. Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $32.00 - MarketBeat
Olema Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals (OLMA) Prices Public Offering at $19 Per S - GuruFocus
OLMA Stock Offering Priced Between $19 and $20 - GuruFocus
Olema Pharma (OLMA) Stock: After-Hours Selloff Hits on Public Offering News - parameter.io
Olema Pharmaceuticals (OLMA) Announces $190M Public Offering - GuruFocus
Olema Oncology dips after $190 mln equity offering following stock surge - TradingView
Olema Oncology announces pricing of $190 million public offering of common stock - MarketScreener
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock - The Manila Times
Olema Oncology (Nasdaq: OLMA) prices $190M public offering of 10M common shares - Stock Titan
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
Olema Pharma (OLMA) Stock Drops as Company Announces Public Offering Plans - CoinCentral
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews
Olema Pharmaceuticals (NASDAQ:OLMA) Sets New 1-Year High After Analyst Upgrade - Defense World
Olema Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals plans public offering of stock, pre-funded warrants; shares down - MSN
Is Olema Pharmaceuticals Inc. stock ready for breakoutJuly 2025 Momentum & Community Supported Trade Ideas - newser.com
Will Olema Pharmaceuticals Inc. stock go up soonWeekly Trading Summary & Stock Portfolio Risk Management - newser.com
Olema Pharmaceuticals (OLMA) Is Up 149.9% After Roche's Positive Breast Cancer Trial Results—Has The Bull Case Changed? - simplywall.st
0.45%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):